Log In
Print this Print this

asunaprevir (Sunvepra) (BMS-650032)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHCV NS3 protease inhibitor
Molecular Target HCV NS3 protease
Mechanism of ActionViral protease inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotype 1 infection; Treat chronic HCV infection; Treat HCV genotype 1 infection in patients who failed previous therapy; Treat HCV genotype 1 infection in treatment-naïve patients; Treat HCV genotype 1b infection
Regulatory Designation

U.S. - Breakthrough Therapy (Treat HCV genotype 1b infection);
U.S. - Undisclosed Review (Treat HCV genotype 1b infection);
Japan - Standard Review (Treat chronic HCV genotype 1 infection)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today